Table 2.
Mean ΔDGE at 8–10 min post injection within the individual ROI
| Pat no | ΔDGE CE (%) | ΔDGE necrosis (%) | ΔDGE FLAIR (%) | ΔDGE WM (%) |
|---|---|---|---|---|
| 1 | 0.25 | 0.16 | 0.05 | |
| 2 | − 0.02 | 0.00 | ||
| 3 | 0.20 | 0.14 | − 0.01 | |
| 4 | − 0.01 | 0.06 | ||
| 5 | 0.41 | − 0.06 | ||
| 6 | 0.04 | 0.03 | − 0.05 | |
| 7 | − 0.04 | 0.01 | 0.01 | |
| 8 | 0.25 | 0.13 | − 0.03 | |
| 9 | − 0.22 | − 0.08 | 0.05 | |
| 10 | 0.23 | 0.37 | 0.06 | |
| 11 | 0.18 | 0.02 |
ROIs of contrast-enhancing tumor, of tumor necrosis, of T2-hyperintense tumor without or faint contrast enhancement, and in normal-appearing white matter were analyzed. Patient no. 7 and 9 were not included in the statistical analysis (marked in italic)